Cancer Vaccines Market Set to Grow Big by 2023

1
Opportunity Analysis and Industry Forecast,
2016-2023
Cancer Vaccines Market
Global Opportunity Analysis and Industry
Forecast, 2017-2023
2
Introduction of Cancer Vaccines Market
The global cancer vaccines market was valued at
4,073 million in 2016, and is projected to reach
at 12,814 million by 2023, growing at a CAGR of
17.7 from 2017 to 2023. The recombinant cancer
vaccines segment accounted for one-third share of
the global market in 2016. Vaccines include
antigenic components, which strengthens an
individuals immune system by developing adaptive
immunity to prevent morbidity from infections.
Cancer vaccine is a type of immunotherapy that
boost the bodys natural defenses by stimulating
the immune system to recognize and cure cancerous
cells. The global market is driven by rise in
prevalence of HPV infections and related cancer,
increase in administration of prophylactic cancer
vaccines, surge in investments findings in the
development of cancer vaccines, and launch of
novel cancer vaccines in the market. However,
longer timelines required for manufacturing a
single vaccine restrain the development of new
vaccines thereby, hampering the market growth.
In addition, high monetary inputs for the
development of cancer vaccines decrease their
adoption in the market thereby, hampering the
market growth.
3
Introduction of Cancer Vaccines Market
Scope of
the Report
Key Benefits Key Audiences
4
 
Key Benefits

• The dendritic cells cancer vaccines segment is
  anticipated to grow at the highest rate during
  the forecast period.
• The preventive cancer vaccines segment dominated
  the global market, accounting for five-ninths
  share of the global market in 2016.
• North America dominated the global market,
  accounting for the maximum share of overall
  market in 2016, and is expected to continue this
  trend throughout the forecast period.
• Asia-Pacific is exhibited to grow at a CAGR of
  19.6 during the forecast period, owing to the
  high demand for vaccination in densely populated
  countries, such as India and China.
• The cervical cancer segment generated the highest
  revenue in 2016, and is expected to continue its
  dominance in the near future.
• The pediatric vaccines segment is expected to
  exhibit high growth rate during forecast period,
  owing to the increase in demand for preventive
  cancer vaccines.

5
 
Table of Content (TOC)
Chapter 1 Introduction Chapter 2 Executive
Summary Chapter 3 Market Overview Chapter 4
Cancer Vaccines Market, By Technology Chapter 5
Cancer Vaccines Market, By Type Chapter 6
Cancer Vaccines, By Indication Chapter 7 Cancer
Vaccines Market, By End Use Chapter 8 Company
Profiles
6
 
Segments Cancer Vaccines Market
7
 
Segments Cancer Vaccines Market
8

Segments Cancer Vaccines Market
9
 
Company Profiles Cancer Vaccines Market

1. ASTRAZENECA PLC. (MEDIMMUNE, LLC.)
2. GLAXOSMITHKLINE PLC.
3. MERCK CO., INC.
4. SANOFI PASTEUR
5. ADURO BIOTECH INC.
6. SANPOWER GROUP CO., LTD.

10
Thank You!
For More Details
Thank You Cancer Vaccines Market
Do Enquiry
https//www.alliedmarketresearch.com/cancer-vaccin
es-market
Follow Us On